Where does Theracos SUB, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Theracos SUB, LLC ranks #43,637 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Theracos SUB, LLC hold?

Theracos SUB, LLC holds 6 US utility patents granted between 2016 and 2021, spanning 6 technology areas.

What is Theracos SUB, LLC's Innovation Score?

Theracos SUB, LLC has an Innovation Score of 25.7 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Theracos SUB, LLC focus on?

Theracos SUB, LLC's top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 4 patents, ranking #217 of 896 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Theracos SUB, LLC's patent grant rate increasing or decreasing?

Theracos SUB, LLC's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Theracos SUB, LLC's patents?

Theracos SUB, LLC's patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Theracos SUB, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Theracos SUB, LLC

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Theracos ranks #43,637 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#43,637
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.7/100): 17.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43637 · US Corporation #43,637 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #43,637/49,997
PHOTO-FINISH THE United States…
CPC-NARROW C07H · 6 areas
INNOV-THIN 25.7/100
CLAIMS-RICH 17.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: THE United States OF America, Department OF Health AND Human Services (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Theracos’s 25.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (26%) Velocity 0.0 pts (0%) Breadth 8.7 pts (34%) Claim depth 10.3 pts (40%)

Qualcomm Incorporated · highest

85
Theracos SUB · this assignee

26
3D Lighting… · lowest

7

What this shows Theracos's Innovation Score is 25.7/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Theracos?

Each dot is one of Theracos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Theracos’s own 17.2 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Theracos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Theracos's grants concentrate

Theracos SUB, LLC is a focused PatentsView assignee: 6 CPC subclasses with 66.7% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2016. By volume, Theracos sits between THE United States OF America, Department OF Health AND Human Services and Thermodyn.

THE United States…

6
THE University OF…

6
THE Viki Group

6
THE Young Enginee…

6
Theravalues

6
Thermik Geraetebau

6
Thermo CRS

6
Thermodyn

6
Theracos SUB ◀

6

What this shows Theracos holds 6 patents at rank #43,538, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Theracos

By rank, the assignees closest to #43,538 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Theracos's primary technology class.

Theracos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Theracos SUB, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	16.7%
2017	2	33.3%
2018	1	16.7%
2020	1	16.7%
2021	1	16.7%

Which technologies does Theracos SUB, LLC patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C07D - Heterocyclic Compounds 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C07C - Acyclic OR Carbocyclic Compounds 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Theracos SUB, LLC's patent record in context - here's where to go next.

Theracos SUB, LLC's lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 66.7% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #43,637 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Theracos SUB, LLC against THE United States OF America, Department OF Health AND Human Services, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.